Eden Research hails 'good progress' with Corteva as it updates on trading
The company is the developer of sustainable biopesticides and plastic-free formulation technology for use in crop protection
Company
Eden Research PLC
LON:EDEN
Eden Research PLC is the UK’s only AIM listed company focused on biopesticides for sustainable agriculture. The company develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its vision is to be a global leader in sustainable crop protection through the development of bioactive products enabled or enhanced by our novel encapsulation and delivery technologies.
170 stories · page 4 of 9
Eden Research says France sign-off for key product opens up significant new market
The company’s biofungicide, Mevalone, has been signed off by regulatory agency ANSES for use in apples and pears
Eden Research shares to begin trading on US OTC today
"The US has one of the largest organic food markets in the world, and its ongoing growth presents a significant opportunity for biopesticide market participants," says boss Sean Smith
Archive
Proactive news headlines: Next Fifteen, S&U, Digitalbox, Mode Global...
A glance at some of the day's highlights from the Proactive Investors newswire
Eden Research chairman expects 'material progress' in the second half
“We now possess internal skills and capabilities that we could only dream of just one year ago, and our operating environment continues to evolve rapidly in Eden's favour. I believe that we are well-positioned to seize the market opportunit
Eden Research receives label extension for sustainable pesticide in Portugal
The product can now be used on more types of fruit and vegetables
Eden Research secures partnership to market fungicide product in North Africa
Mevalone will be marketed as Araw in Egypt, Morocco, Algeria and Tunisia
Archive
Proactive headlines: Eden Research, FastForward Innovations, Coinsilium…
A look at some of today's major headlines from the Proactive newswire
Eden Research receives first sign-off for products in Morocco and Romania
The company is a specialist in sustainable biopesticides and plastic-free formulation technology
Eden Research eyes US approval of lead products Mevalone, Cedroz
This year, the group will build on the sales achieved in the territories where it received approvals in 2020
Archive
Proactive news headlines: Eden Research, Primary Health Properties, Silence Therapeutics, IronRidge Resources...
A glance at some of the day's highlights from the Proactive Investors newswire
Eden Research agrees 'milestone' seed treatment deal with US agriscience giant Corteva
The American group has landed the exclusive commercialisation, supply and distribution rights covering the EU, UK and Serbia
Eden Research’s Cedroz pesticide receives approval from Italian regulators
Italy is the EU's second-largest producer of fruit and vegetables, growing 10mln tonnes of fruit and around 7mln tonnes of vegetables annually
Eden Research partner gets the green light in Spain for bio-fungicide
Chief executive Sean Smith said: "This expansion of the label for ARAW in Spain represents a meaningful increase in Eden's addressable market."
Eden Research proves resilient as it exits 2020 well funded
Chief executive Sean Smith said: “It has been an unprecedented year for businesses across the globe, and Eden has not been immune to the disruption caused by the COVID-19 pandemic."
Eden Research says London Stock Exchange formally recognises group's green credentials
Adherence to good environmental, social and governance (ESG) principles has become a fundamental part of investment
Eden Research hoping to get to the root of plant fungus problem
A family-owned farm in Yorkshire has done some initial trials on investigating the effect of mugwort plant extract on key plant diseases and now Eden Research is getting involved
Eden Research hails progress in expanding its business resources
The board remains confident in the market opportunity for biopesticides, which is growing at CAGR of about 15% p.a. and is projected to be worth more than US$10 billion by 2025.
Eden Research says commercial collaborator, Eastman Chemical has received authorisation for the sale of Cedroz in France
The group also said the French regulator has also approved Eden's biofungicide, Mevalone, for use in organic agriculture in France
Eden Research says patent behind its Sustaine encapsulation technology has been granted in Australia
The patent is for 'Encapsulation of High Potency Actives' allowing for the combination of Sustaine with a wide range of active ingredients from third parties.